
Factors Associated With Major Bleeding Events : Insights From the ROCKET AF Trial (Rivaroxaban Once-daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation)
Keywords: HR، نسبت خطر; anticoagulants; atrial fibrillation; hemorrhageAF, atrial fibrillation; ASA, acetylsalicylic acid; CI, confidence interval; COPD, chronic obstructive pulmonary disease; DBP, diastolic blood pressure; GI, gastrointestinal; HR, hazard ratio; INR, internatio